Functional Ability and Elimination Study Notes

Functional Ability: Elimination Overview and Resources

Elimination is a central component of functional ability. Knowledge regarding these conditions is drawn from several key academic resources:

  • ATI PN Adult Medical Surgical Nursing: Chapters 46 and 56.
  • Brunner Medical Surgical Text.

Key exemplars for study include:

  • Benign Prostatic Hyperplasia (BPH)
  • Urinary calculi
  • Bowel Obstruction
  • Encopresis and Enuresis
  • Hypospadias

Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia is a non-cancerous enlargement of the prostate gland. It is a condition commonly identified in older men, where the enlarged prostate compresses the urethra and results in various urinary problems.

Pathophysiology
  • The prostate gland increases in size.
  • Consequently, the urethra becomes compressed.
  • Urine flow is obstructed, which prevents the bladder from emptying completely.
Causes and Risk Factors

Causes:

  • Aging.
  • Hormonal changes.
  • Neurologic Disease.

Risk Factors:

  • Age over 50.
  • Family history.
  • Obesity.
  • Diabetes.
Signs and Symptoms

A common memory tip for this condition is "BPH blocks pee flow." Symptoms include:

  • Frequent urination.
  • Nocturia (the need to urinate at night).
  • Weak urine stream.
  • Difficulty starting urination.
  • Dribbling after urination.
  • Urinary retention.
Prevalence Across the Lifespan
  • BPH is not observed in pediatric populations; it is conditions of older men.
  • At age 50, approximately 50%50\% of men are affected.
  • By age 80, the prevalence increases to 90%90\%.
Diagnosis
  • Digital rectal exam (DRE).
  • Urinary flow test.
  • Post-void residual (PVR) volume test.
  • 24-hour voiding diary.
  • Ultrasound.
  • Urinalysis (UA).
  • Prostate-specific antigen (PSA) blood test: PSA is a protein produced by prostate cells. A normal value is less than 4.0 ng/ml4.0\,ng/ml.
Treatment Modalities

Lifestyle Changes:

  • Reduction of caffeine intake.
  • Limiting fluid intake in the evening.
  • Regular exercise.

Medications:

  • Alpha Blockers (e.g., Tamsulosin).
  • 5-Alpha Reductase Inhibitors (e.g., Finasteride).

Minimally Invasive Procedures:

  • Transurethral microwave heat treatment (TUMT).
  • Transurethral needle ablation (TUNA): Low-level radiofrequency is transmitted to the prostate via a transurethral needle delivery system, causing localized necrosis via heat.
  • Stent insertion.

Surgical Interventions:

  • Transurethral Resection of the Prostate (TURP): Considered the surgical benchmark procedure. It involves cutting out the middle of the enlarged prostate to improve urine flow.
  • Radical Prostatectomy: Utilized in severe cases.
Pharmacological Management of BPH

Alpha-1A Antagonists ("-osin"):

  • Examples: Tamsulosin hydrochloride (Flomax), Terazosin (Hytrin), Doxazosin (Cardura), Alfuzosin (Uroxatral), Silodosin (Rapaflo).
  • Action: These relax certain muscles and help small blood vessels remain open by preventing norepinephrine from tightening the muscles in the walls of smaller arteries and veins. They also relax the bladder neck smooth muscle to allow for earlier flow.
  • Side Effects: Dizziness, decreased blood pressure (low blood pressure).

5-Alpha-Reductase Inhibitors ("-asteride"):

  • Examples: Finasteride (Proscar), Dutasteride (Avodart).
  • Action: These medications shrink the prostate by preventing hormonal changes that cause growth.
  • Note: These may take up to six months to become effective.
  • Side Effects: Retrograde ejaculation, loss of libido.
Post-Operative TURP Care

Nursing monitoring should include assessments for bleeding, blood clots, infection, and bladder spasms.

  • Normal Finding: Light pink urine.
  • Immediate Reporting Required: Bright red bleeding with large clots.

Continuous Bladder Irrigation (CBI): Utilizes a three-way catheter connected to an irrigation solution bag, a bulb inflation port, and a catheter drainage bag.

Renal Calculi (Urinary Stones)

Renal calculi involves the presence of stones within the urinary system.

  • Urolithiasis: Stones located in the urinary tract.
  • Nephrolithiasis: Stones located in the kidney.
Prevalence and Statistics
  • Affects 1 in 11 people in the U.S.
  • Higher prevalence in males (11%11\%) than females (7%7\%), though rates are increasing among females.
  • Recurrence rates: 15%15\% in the first year and 50%50\% within 10 years.
Factors Influencing Stone Formation
  • Infection and urinary stasis.
  • Periods of immobility.
  • Increased calcium concentrations: Hypercalcemia and hypercalciuria (caused by hyperparathyroidism, renal tubular acidosis, cancers).
  • Dehydration (not drinking enough fluid).
  • Excessive Vitamin D intake.
  • Granulomatous diseases.
  • Myeloproliferative diseases.
  • Intestinal bypass surgery.
  • Elevated Uric Acid or Urinary oxalate levels.
Clinical Manifestations

Symptoms depend on the presence of obstruction, infection, and edema. General symptoms include stomach pain, backache, vomiting, dizziness, fever, and blood in the urine.

  • Renal Region: Intense, deep ache in the costovertebral region radiating anteriorly and downward; hematuria (blood in urine) and pyuria (pus in urine) may occur.
  • Renal Colic: Acute pain accompanied by nausea and vomiting.
  • Ureteral Colic: Colicky, wavelike pain radiating to the thigh and genitalia.
  • Bladder Stones: Irritation, UTI symptoms, hematuria, and urinary retention.
Stages of Kidney Stone Symptoms
  1. Stage 1: A stone does not cause pain until it dislodges from inside the kidney.
  2. Stage 2: A stone in the ureter can set off severe bouts of pain.
  3. Stage 3: In the bladder, stones may cause frequent urination, weak stream, and urinary retention.
  4. Stage 4: Passing the stone may cause pain in the urethra.
Diagnosis of Renal Calculi
  • Urinalysis (UA).
  • Intravenous Pyelogram (IVP).
  • Cystoscopy.
  • Renal Stone Analysis.
  • KUB X-ray (Kidneys, Ureters, Bladder).
  • Serum tests: Calcium, Oxalate, Uric acid.
Management and Interventional Procedures

Goals include eradicating the stone, determining the type, preventing nephron destruction, controlling infection, and relieving obstruction. The immediate objective for colic is pain relief.

Interventions:

  • Ureteroscopy: Visualizing and destroying the stone using a laser, lithotripter, or ultrasound. A stent may be inserted to keep the ureter patent.
  • Extracorporeal Shock Wave Lithotripsy (ESWL): A noninvasive procedure using shock waves to break stones into small fragments excreted in urine.
  • Endourologic Methods: Percutaneous nephrostomy or nephrolithotomy (PCNL) involves extracting stones with forceps or retrieval baskets through a small incision.
Dietary and Lifestyle Modifications by Stone Type
  • Uric Acid Stone: Requires a low purine diet. Patients must decrease or stop eating shellfish, anchovies, asparagus, mushrooms, and organ meats. Medication: Allopurinol.
  • Cystine Stone: Low protein diet and increased fluids.
  • Oxalate Stones: Decrease or stop eating spinach, strawberries, rhubarb, chocolate, tea, peanuts, and wheat bran.
Patient Education and Self-Care
  • Fluid Intake: Maintain high intake to excrete more than 2,000 mL2,000\,mL of urine daily.
  • Testing: Perform urine cultures every 12 months initially.
  • Activity: Increase mobility to prevent renal drainage issues and altered calcium metabolism.
  • Avoidance: Steer clear of excessive vitamins and minerals.
Pediatrics and Renal Calculi

Incidence is increasing in children. The Southern U.S. is referred to as the "stone belt." Symptoms and treatments in children are similar to those in adults.

Intestinal and Bowel Obstruction

Bowel obstruction is a partial or complete blockage that prevents the normal passage of food, fluids, gas, and stool.

Types of Obstruction
  1. Mechanical Obstruction: Physical blockages such as adhesions, hernias, abscesses, tumors, intussusception, volvulus, stenosis, strictures, or constipation.
  2. Functional/Paralytic Obstruction: Resulting from disorders that stop peristalsis, such as Amyloidosis, muscular dystrophy, endocrine disorders (diabetes), or neurologic disorders (Parkinson disease).
Small Bowel Obstruction (SBO) vs. Large Bowel Obstruction (LBO)
  • Small Bowel Obstruction (SBO): More common, characterized by rapid fluid loss. Vomiting is often bilious.
  • Large Bowel Obstruction (LBO): Slower onset, constipation is prominent, abdominal distention is more significant. Blood loss in stool is possible. Vomiting may be fecal-smelling.
Causes
  • Adhesions (scar tissue): The most common cause (>50%> 50\%, often postoperative).
  • Hernias: Protrusion of the intestine through abdominal muscles.
  • Neoplasm/Tumors.
  • Volvulus: The loop of the intestine twists around itself.
  • Intussusception: One part of the intestine slips into another (telescoping).
Signs and Symptoms
  • Early: Crampy abdominal pain in waves, nausea, vomiting, distention, decreased appetite, and high-pitched "tinkling" bowel sounds.
  • Late: No flatus, no bowel movement, severe distention, dehydration, and silent abdomen (no bowel sounds).
  • Emergency Indicators: Sudden relief of severe pain (possible rupture), fever (ischemia/infection), rigid abdomen, and signs of shock (low BP, fast HR).
Diagnostic Findings
  • Abdominal X-ray, CT, and MRI are used.
  • Barium studies are contraindicated.
  • X-ray shows a "step-ladder" air-fluid level pattern.
  • In SBO, dilated loops are typically greater than 3 cm3\,cm and located centrally.
  • Valvulae Conniventes: Anatomical folds of the small bowel that become apparent when distended.
  • "String of Pearls" Sign: Small gas bubbles trapped in the folds.
Medical and Nursing Management
  • Decompression: Immediate use of a Nasogastric (NG) tube connected to low wall suction.
  • NPO (Nothing by mouth) status.
  • IV Fluid and electrolyte replacement: Monitor for low potassium (K+K^+), low sodium (Na+Na^+), and hypovolemia.
  • Medications: Promethazine, Ondansetron.
  • Surgical Intervention: Bowel resection or temporary/permanent colostomy.
Memory Tip: "STOP FLOW"
  • S: Silent bowels late
  • T: Tender, distended abdomen
  • O: Obstruction (no stool/gas)
  • P: Pain cramping early
  • F: Fluid loss (vomiting/dehydration)
  • L: Low electrolytes
  • O: Output (NG tube needed)
  • W: Watch for surgery

Specialized Pediatric Conditions

Hirschsprung Disease
  • Definition: A congenital defect involving an a-ganglionic length of the colon.
  • Clinical Manifestations: Appears in early infancy; failure to pass a meconium stool within 24 hours, constipation, progressive abdominal distention, and anorexia.
  • Diagnosis: H&P, unprepped barium enema, and biopsy.
  • Treatment: Surgical resection of the affected colon.
  • Nursing: Support infant-parent bonding, teach colostomy care, and advise a lifelong high-fiber diet.
Intussusception
  • Manifestations: Infants/toddlers drawing up legs and crying intermittently, bile-stained or fecal emesis.
  • Stools: Descibed as "currant jelly" (mixture of mucous and blood).
  • Physical Exam: Sausage-shaped mass in the Right Upper Quadrant (RUQ) and the Dance sign (an empty Right Lower Quadrant).
Hypospadias and Epispadias

Both are discovered at birth assessment. Circumcision is avoided as the foreskin is needed for surgical repair.

  • Hypospadias: Urethral opening is on the ventral surface (underside) of the penis. Symptoms include abnormal urine stream and curved penis (chordee). Post-op may require urinary diversion with a stent and double diapering.
  • Epispadias: Urethral meatus is on the dorsal surface (top) of the penis. Often associated with bladder exstrophy. The scrotum may appear small, with non-palpable testes. Surgical correction involves urethral/penile lengthening and bladder neck construction.
Enuresis
  • Definition: Involuntary urination after age 5.
  • Types:
    • Nocturnal: Bedwetting at night.
    • Diurnal: Daytime wetting.
    • Primary: Never achieved dryness.
    • Secondary: Wetting after staying dry for at least 6 months.
  • Diagnosis: UA and Voiding cystourethrogram (VCUG).
  • Treatment: Desmopressin (DDAVP) to mimic antidiuretic hormone; Imipramine (Tofranil) to relax bladder muscles and lighten sleep.
Encopresis
  • Definition: Repeated passage of stool in inappropriate places in a child older than 4, usually associated with chronic constipation.
  • Symptoms: Soiled underwear, abdominal pain, poor appetite, child hiding dirty clothes.
  • Treatment: Clearing the colon of impacted stool, high-fiber diet, increased fluids, and behavioral therapy (sitting on the toilet for 20-30 minutes after meals).

Opioid-Induced Constipation (OIC)

Pathophysiology

Opioids activate Mu receptors, which leads to:

  • Decreased bowel tone and contractility.
  • Increased colonic fluid absorption.
  • Increased anal sphincter tone.
  • Reduced rectal sensation.
Treatment

Prevention includes dietary fiber, fluid intake, and exercise. Most laxatives can be used, excluding bulk-forming laxatives.

  • Methylnaltrexone bromide (Relistor): Does not cross the blood-brain barrier (avoiding withdrawal). Contraindicated in PUD, diverticulosis, or obstruction.
  • Lubiprostone (Amitiza): A type-2 chloride channel activator that increases GI fluid secretion.

Elimination Diets: Specific Conditions

  • GERD: Avoid alcohol, chocolate, coffee, cow's milk, saturated fat, orange juice, spicy foods, tea, tomato juice, and mints.
  • ADHD: Avoid food additives, artificial colors/flavors, and artificial sweeteners.
  • Rheumatoid Arthritis: Avoid corn, dairy, and nightshade vegetables (peppers, eggplant, potatoes, tomatoes).
  • Autism Spectrum Disorder: Avoid gluten and casein (wheat, oats, barley, rye, dairy).
  • Eczema: Children should avoid dairy, eggs, soy, and wheat. Adults should avoid certain fruits and nuts.
  • General Recommendation: Focus on whole, unprocessed foods, lean proteins (beef, chicken, lamb, pork, turkey), fresh vegetables, and healthy fats.